Výsledky vyhledávání - "Kana Ishimori"

Akademický článek

Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.

Autor: Hironari Hanaoka, Tomofumi Kiyokawa, Harunobu Iida, Kana Ishimori, Yukiko Takakuwa, Takahiro Okazaki, Hidehiro Yamada, Daisuke Ichikawa, Sayuri Shirai, Junki Koike, Shoichi Ozaki

Publikováno v: PLoS ONE, Vol 12, Iss 4, p e0175152 (2017)

The recent recommendations for the management of lupus nephritis suggest that racial background should be considered while choosing induction therapy. However, the responses to different induction regimens have been poorly studied in Japanese populat

Externí odkaz: https://doaj.org/article/e4f02cb9fc2b48bc8c3e2cd053c01b2a

Zobrazit plný text záznamu

High plasma mycophenolate acid concentration in the early phase of induction therapy predicts good renal outcome in lupus nephritis

Autor: Shoichi Ozaki, Hironari Hanaoka, Kimito Kawahata, Takahiro Okazaki, Harunobu Iida, Yukiko Takakuwa, Kana Ishimori, Tomofumi Kiyokawa

Publikováno v: Modern rheumatology. 30(3)

Objectives: To identify the prognostic predictive factor of complete renal response (CR) at week 12 by focusing on the plasma mycophenolic acid (MPA) concentration in induction therapy in lupus nep...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84fffeac05c28f3f7947255510bcb4b4
https://pubmed.ncbi.nlm.nih.gov/31135249

Zobrazit plný text záznamu

Anti-IL-10 antibody in systemic lupus erythematosus

Autor: Marina, Uchida, Seido, Ooka, Yutaka, Goto, Kanako, Suzuki, Hisae, Fujimoto, Kana, Ishimori, Hiromi, Matsushita, Yukiko, Takakuwa, Kimito, Kawahata

Publikováno v: Open Access Rheumatology : Research and Reviews

Purpose IL-10 is a cytokine known to inhibit inflammatory cytokines. To determine its role in the pathogenesis of systemic lupus erythematosus (SLE), the presence of anti-IL-10 antibody is required to be examined. Although antibodies against cytokine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d8c919c39f3bcf05396b4cf47e09e8f2
https://pubmed.ncbi.nlm.nih.gov/30988645

Zobrazit plný text záznamu

Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse

Autor: Yukiko, Takakuwa, Hironari, Hanaoka, Tomofumi, Kiyokawa, Harunobu, Iida, Kana, Ishimori, Toshimasa, Uekusa, Hidehiro, Yamada, Kimito, Kawahata

Publikováno v: Clinical and experimental rheumatology. 37(6)

Adult-onset Still's disease (AOSD) is an inflammatory disorder characterised by sustained fevers, arthritis, and skin involvement. Interstitial lung disease (ILD) is a rare manifestation, and its clinical characteristics have yet to be determined.We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e37a9f79e9d7de5ed03bba615cce925a
https://pubmed.ncbi.nlm.nih.gov/30767871

Zobrazit plný text záznamu

Rhabdomyolysis in a Patient with Polyarteritis Nodosa

Autor: Tomofumi Kiyokawa, Kana Ishimori, Harunobu Iida, Yoshioki Yamasaki, Shoichi Ozaki, Hironari Hanaoka, Yukiko Takakuwa, Masatomo Doi, Yusa Asari, Hidehiro Yamada, Takahiro Okazaki

Publikováno v: Internal Medicine

Polyarteritis nodosa (PAN) is a medium vessel vasculitis affecting systemic organs. Muscle involvement of PAN usually lacks elevation of creatinine kinase (CK). We herein report a case of PAN with rhabdomyolysis. A 71-year-old man was hospitalized be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba34264ec90207b42788c581ea3b239e
https://pubmed.ncbi.nlm.nih.gov/29021478

Zobrazit plný text záznamu

AB0597 Low-dose rituximab as induction therapy for japanese patients with anca-associated vasculitis

Autor: Shoichi Ozaki, Kana Ishimori, Yukiko Takakuwa, Hironari Hanaoka, Harunobu Iida, Takahiro Okazaki, Tomofumi Kiyokawa, Hiroko Nagafuchi

Publikováno v: Abstracts Accepted for Publication.

Background Four times of once-weekly doses of 375 mg/m 2 rituximab (RTX) are frequently used as remission induction therapy for ANCA-associated vasculitis (AAV). Since this regimen has been basically generated from experience of B-cell non-Hodgkins9

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::32717c4b6f46d95796288a1ac042eee9
https://doi.org/10.1136/annrheumdis-2017-eular.5410

Zobrazit plný text záznamu

SAT0259 High plasma concentration of mycophenolate acid in early phase of induction therapy predicts good renal outcome in lupus nephritis class iii or iv

Autor: Tomofumi Kiyokawa, Shoichi Ozaki, Kana Ishimori, Hironari Hanaoka, Takahiro Okazaki, Yukiko Takakuwa, Harunobu Iida

Publikováno v: Poster Presentations.

Background Mychophenolate mofetil (MMF) is recommended as initial induction treatment for most cases of lupus nephritis (LN) class III-IV. Although the association between area under the concentration-versus-time curve (AUC) of myochophenolate acid (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::efadd9ea42390ef5a2081aec5f3ee94b
https://doi.org/10.1136/annrheumdis-2017-eular.4622

Zobrazit plný text záznamu

Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study

Autor: Junki Koike, Hironari Hanaoka, Daisuke Ichikawa, Shoichi Ozaki, Hidehiro Yamada, Tomofumi Kiyokawa, Takahiro Okazaki, Yukiko Takakuwa, Harunobu Iida, Sayuri Shirai, Kana Ishimori

Publikováno v: PLoS ONE, Vol 12, Iss 4, p e0175152 (2017)
PLoS ONE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0ccc5aa2764cd4c3eb4cf28835f3369
http://europepmc.org/articles/PMC5383240?pdf=render

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání